These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 3317354
21. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India. Velu V, Nandakumar S, Shanmugam S, Shankar EM, Thangavel S, Kulkarni PS, Thyagarajan SP. Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812 [Abstract] [Full Text] [Related]
22. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination. Evans TG, Schiff M, Graves B, Agosti J, Barritt ML, Garner D, Holley JL. Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690 [Abstract] [Full Text] [Related]
23. Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial. Bock M, Barros E, Veronese FJ. Nephrology (Carlton); 2009 Apr; 14(3):267-72. PubMed ID: 19207871 [Abstract] [Full Text] [Related]
24. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers. Thaithumyanon P, Punnahitananda S, Praisuwanna P, Thisyakorn U, Ruxrungtham K. J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014 [Abstract] [Full Text] [Related]
25. [Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children]. Liang Z, Li C, Jing Q. Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):165-7. PubMed ID: 10322792 [Abstract] [Full Text] [Related]
26. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine]. Zhao YL, Chen YG, Li J, Han GX, Tian C, Liang JL, Li G, Wang ZG, Zhu YG, Tian ZN, Zhang HY, Wan ZJ, Liang ZL, Bi SL. Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119 [Abstract] [Full Text] [Related]
27. Results of vaccinated infants born to HBsAg-positive mothers with different hepatitis B vaccines and doses. Kuru U, Turan O, Kuru N, Sağlam Z, Alver A. Turk J Pediatr; 1995 Jun; 37(2):93-102. PubMed ID: 7597774 [Abstract] [Full Text] [Related]
30. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years. Kurugöl Z, Mutlubaş F, Ozacar T. Vaccine; 2005 Apr 22; 23(22):2876-80. PubMed ID: 15780736 [Abstract] [Full Text] [Related]
31. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children. Yuen MF, Lim WL, Cheng CC, Lam SK, Lai CL. Hepatology; 1999 Mar 22; 29(3):924-7. PubMed ID: 10051499 [Abstract] [Full Text] [Related]
35. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine]. Gałaj A, Grześk G, Borys D, Durmowicz A, Grześk E, Szadujkis-Szadurski L. Wiad Lek; 2004 Dec 02; 57(5-6):217-20. PubMed ID: 15518064 [Abstract] [Full Text] [Related]
36. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin. Anandh U, Thomas PP, Shastry JC, Jacob CK. J Assoc Physicians India; 2000 Nov 02; 48(11):1061-3. PubMed ID: 11310381 [Abstract] [Full Text] [Related]
38. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children. Duval B, Gîlca V, Boulianne N, Deceuninck G, Rochette L, De Serres G. Vaccine; 2005 Jul 01; 23(31):4082-7. PubMed ID: 15963363 [Abstract] [Full Text] [Related]
40. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization. Radziszewski A, Gajda M, Pituch-Noworolska A, Drozdz M, Kraśniak A, Kaczmarczyk I, Hołyś S, Zurowski J, Sydor A, Sułowicz W. Przegl Lek; 2007 Jul 01; 64(7-8):470-5. PubMed ID: 18409347 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]